SyBridge Technologies, provider of design and manufacturing solutions across multiple industries, announced it acquired Cavaform, Inc., a tight tolerance precision tooling and molding market. This transaction represents Sybridge's 15th acquisition since its inception in 2019.
Headquartered in St. Petersburg, Florida, Cavaform expands SyBridge's presence in the high precision life sciences end-market. Cavaform's wholly owned subsidiary, MTM&D, is a leader in supportive molding for a wide range of life science and consumer applications.
For more than 40 years, Cavaform has been known for its innovative solutions in close tolerance tooling. Cavaform's customers range across many end markets but is renowned for its solutions in the medical disposables, personal care and intravenous (IV) catheter tipping tool industries. In 2008, Cavaform started MTM&D as a testing and qualifications business, which quickly expanded into full "art to part" molding offerings.
New York-based private equity firm Crestview Partners established SyBridge Technologies in 2019 to create and build a market leading value-added manufacturing solutions provider spanning end-markets, geographies, and advanced technological capabilities.
"Cavaform is another important step in our transformation to be the partner of choice for advanced technology-driven design and manufacturing solutions,” says Byron J. Paul, CEO of SyBridge Technologies. “Cavaform and MTM&D adds to our capabilities in high precision tooling for the life-sciences segment and extends our ability to fulfill needs across the product lifecycle."
"We are pleased to join and be a part of SyBridge Technologies' growing family of exciting companies,” says Dave Massie, Owner and President of Cavaform. “The combination of Cavaform's experience and SyBridge's breadth of design, prototyping, tooling and software capabilities creates an exciting platform for growth."
